InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by O'Quinn Shari L. Officer active across 2 companies, notably TriVascular Technologies, Inc.. In total, 7 disclosures have been published. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
O'Quinn Shari L is a declarant linked to TriVascular Technologies, Inc. and ENDOLOGIX INC /DE/, where the listed roles are VP Clinical/Regulatory Affairs and VP, Clinical & Regulatory. The record shows 7 filings, and within the recent filings observed, the period runs from 2016-02-04 to 2016-02-05, with the modal transaction nature listed as option exercise.